glp-1 and cancer risk Forest plot of receptor agonists versus comparators on of GLP-1 meds slow cancer progression

10.1104/pp.106.079475 50 OkudaS.WatanabeY.MoriyaY.KawanoS.YamamotoT.MatsumotoM.et al

Resolving the role of lipoxygenases in the initiation and execution of ferroptosis

Noom Meds GLP-1 Rx Program: A Personalized, Integrated Solution Nooms approach to individualized treatment was designed in consultation with obesity clinicians from the ground up to solve the adherence puzzle and deliver on the full promise of GLP-1 therapy, when a patient is identified to be at higher risk of discontinuation

American journal of epidemiology

This allows the body to use fat stores as fuel, increasing energy levels and endurance during workouts